Interview with Scott Sand of IGNT

Ingen Technologies, Inc. (OTC: IGNT) is an emerging medical device manufacturer in the $4 Billion respiratory industry. Recently FDA approved, Oxyview was introduced into the medical market in late 2007, and now has global distribution. Ingen founders invested several millions of dollars in the research and development of state-of-the-art respiratory monitoring devices, with a focus on helping patients and preventing unnecessary costs to the healthcare system. With multiple patents, FDA classification and certifications, Ingen is the largest manufacturer of gravity-independent in-line oxygen flow meters, meeting the demand of the growing patient population and service providers. Ingen products are manufactured in the USA, and with approval to sell its products in China as well as distribution partners in Middle East, the Company is rapidly expanding its distribution channels to bring its products to a global customer base. With literally tens of millions of suffering in America alone from various respiratory diseases that often require oxygen therapy, the unique technologies offered by Ingen have tremendous applications and the potential to substantially improve conditions for sufferers.

Listen now! (5:21min / 4.9MB)

Interview with Mathew Zuckerman

Alkane, Inc. (OTC: ALKN) uses patent pending and proprietary methodologies to develop, produce and market a range of fuel and fuel enhancement products. The company’s first product, Monster Diesel™, is a patent-pending total fuel additive that boosts diesel fuel to premium levels and satisfies all of a diesel engine’s needs in one product. Among the most important benefits of using Monster Diesel™ is that it is cost effective for truckers, boaters, bus operators, or home owners who heat with oil. In addition, continued helps to reduce emissions and fuel consumption, issues that have become paramount given the increased level of emphasis on greener technologies and growing concerns over global fuel supplies.

Listen now! (4:28min / 4.1MB)

Interview with Naresh Belwal of BRNW

BrainyBrawn, Inc. (OTC: BRNW) focuses on providing affordable and discounted healthcare products and services to consumers in the USA, as well as automation and software products and services to healthcare providers and practitioners in the burgeoning healthcare industry in India, through a license Agreement with, and intended acquisition of, Sanvi Infotech Private Limited based in India. The Company expects a substantial demand among healthcare providers in India for products and services to help support and market their health care practices with innovative technology and business solutions such as office and business automation and information management software. Sanvi Infotech Private Limited has developed and launched a suite of comprehensive information management software solutions for healthcare providers such as physicians, pharmacies, diagnostic labs, small hospitals and more. The Company has entered into a letter of intent to acquire a majority stake in Sanvi Infotech Private Limited by April 15, 2009.

Listen now! (4:14min / 3.9MB)

Interview with Scott Sand of ITEC

Ingen Technologies, Inc. (OTC: ITEC) is an emerging medical device manufacturer in the $4 Billion respiratory industry. Recently FDA approved, Oxyview was introduced into the medical market in late 2007, and now has global distribution. Ingen founders invested several millions of dollars in the research and development of state-of-the-art respiratory monitoring devices, with a focus on helping patients and preventing unnecessary costs to the healthcare system. With multiple patents, FDA classification and certifications, Ingen is the largest manufacturer of gravity-independent in-line oxygen flow meters, meeting the demand of the growing patient population and service providers. Ingen products are manufactured in the USA, and with approval to sell its products in China as well as distribution partners in Middle East, the Company is rapidly expanding its distribution channels to bring its products to a global customer base. With literally tens of millions of suffering in America alone from various respiratory diseases that often require oxygen therapy, the unique technologies offered by Ingen have tremendous applications and the potential to substantially improve conditions for sufferers.

Listen now! (4:19min / 4MB)

Interview with Tian Yuan of CHFY

China Forestry, Inc. (OTC: CHFY) is a forest investment group offering U.S. investors the unique opportunity to participate in the booming Chinese forestry industry. The Company’s forestry business manages 1,561 hectares divided among four parcels of private commercial forestland in Heilongjiang Province, the People’s Republic of China. It has the right to use all of those hectares pursuant to a usage lease for terms of from fifty to more than sixty-five years from the provincial government. China Forestry’s mission is to capitalize on the growing disparity between China’s consumption levels of timber and forestry products, and the country’s current inability to meet this surging demand. At present, China is both the world’s single largest consumer and the world’s largest importer of timber. Sustained economic development and continued growth appear likely to continue this trend, resulting in tremendous potential demand for the type of scarce forest resources that China Forestry controls.

Listen now! (5:10min / 4.7MB)